NCT02609230 · Interventional trial
A Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma
Overall registry status Completed
Phase 1
Conditions Advanced Solid Tumors, Multiple Myeloma
Delaware Valley sites
- Fox Chase Cancer Center - Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory